These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2013743)

  • 1. Disappearance half-life times of exogenous and growth hormone-releasing factor-stimulated endogenous growth hormone in normal rats.
    Chapman IM; Helfgott A; Willoughby JO
    J Endocrinol; 1991 Mar; 128(3):369-74. PubMed ID: 2013743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin.
    Faria AC; Veldhuis JD; Thorner MO; Vance ML
    J Clin Endocrinol Metab; 1989 Mar; 68(3):535-41. PubMed ID: 2563734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action.
    Fairhall KM; Mynett A; Robinson IC
    J Endocrinol; 1995 Mar; 144(3):555-60. PubMed ID: 7738479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of endogenous growth hormone pulsatility in gelded yearling horses using deconvolution analysis.
    de Graaf-Roelfsema E; Veldhuis PP; van Dam KG; Menheere PP; Keizer HA; Johnson ML; van Breda E; Wijnberg ID; van der Kolk JH
    Vet Q; 2011 Jun; 31(2):63-71. PubMed ID: 22029850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glucocorticoid treatment and acute passive immunization with growth hormone-releasing hormone and somatostatin antibodies on endogenous and stimulated growth hormone secretion in the male rat.
    Miell J; Corder R; Miell PJ; McClean C; Gaillard RC
    J Endocrinol; 1991 Oct; 131(1):75-86. PubMed ID: 1683888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The half-life of exogenous growth hormone after suppression of endogenous growth hormone secretion with somatostatin.
    Hindmarsh PC; Matthews DR; Brain CE; Pringle PJ; di Silvio L; Kurtz AB; Brook CG
    Clin Endocrinol (Oxf); 1989 Apr; 30(4):443-50. PubMed ID: 2574646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic clearance rate of biosynthetic growth hormone after endogenous growth hormone suppression with a somatostatin analogue in chronic renal failure patients and control subjects.
    García-Mayor RV; Pérez AJ; Gandara A; Andrade A; Mallo F; Casanueva FF
    Clin Endocrinol (Oxf); 1993 Sep; 39(3):337-43. PubMed ID: 8222296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evidence of a positive role for somatostatin to optimize pulsatile growth hormone secretion.
    Turner JP; Tannenbaum GS
    Am J Physiol; 1995 Oct; 269(4 Pt 1):E683-90. PubMed ID: 7485482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term adult exposure to estradiol feminizes the male pattern of spontaneous and growth hormone-releasing factor-stimulated growth hormone secretion in the rat.
    Painson JC; Thorner MO; Krieg RJ; Tannenbaum GS
    Endocrinology; 1992 Jan; 130(1):511-9. PubMed ID: 1345780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rebound release of growth hormone (GH) following somatostatin infusion in rats involves hypothalamic GH-releasing factor release.
    Clark RG; Carlsson LM; Rafferty B; Robinson IC
    J Endocrinol; 1988 Dec; 119(3):397-404. PubMed ID: 2906083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The episodic secretory pattern of growth hormone regulates liver carbonic anhydrase III. Studies in normal and mutant growth-hormone-deficient dwarf rats.
    Jeffery S; Carter ND; Clark RG; Robinson IC
    Biochem J; 1990 Feb; 266(1):69-74. PubMed ID: 1968744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent reduction and potentiation of growth hormone (GH) responsiveness to GH-releasing factor induced by exogenous GH: role for somatostatin.
    Lanzi R; Tannenbaum GS
    Endocrinology; 1992 Apr; 130(4):1822-8. PubMed ID: 1347739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a primary involvement of somatostatin in clonidine-induced growth hormone release in conscious rats.
    Lanzi R; Lapointe M; Gurd W; Tannenbaum GS
    J Endocrinol; 1994 May; 141(2):259-66. PubMed ID: 7913948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal of endogenous somatostatin induces secretion of growth hormone-releasing factor in rats.
    Miki N; Ono M; Shizume K
    J Endocrinol; 1988 May; 117(2):245-52. PubMed ID: 2897995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide administration, under particular temporal conditions, enhances the responses of growth hormone to growth hormone-releasing hormone in normal subjects.
    Valcavi R; Zini M
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):379-82. PubMed ID: 8187302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin.
    Tannenbaum GS; Lapointe M; Gurd W; Finkelstein JA
    Endocrinology; 1990 Dec; 127(6):3087-95. PubMed ID: 1979030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of hypothalamic stimulation on growth hormone (GH) release induced by GH-releasing factor in the rat.
    Kato M; Suzuki M; Kakegawa T
    Endocrinology; 1985 Jan; 116(1):382-8. PubMed ID: 3917251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide.
    Renner U; Brockmeier S; Strasburger CJ; Lange M; Schopohl J; Müller OA; von Werder K; Stalla GK
    J Clin Endocrinol Metab; 1994 May; 78(5):1090-6. PubMed ID: 8175966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone responses to multiple injections of a fragment of human growth hormone-releasing factor in conscious male and female rats.
    Clark RG; Robinson IC
    J Endocrinol; 1985 Sep; 106(3):281-9. PubMed ID: 2864380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual dimorphism of somatostatin and growth hormone-releasing factor signaling in the control of pulsatile growth hormone secretion in the rat.
    Painson JC; Tannenbaum GS
    Endocrinology; 1991 Jun; 128(6):2858-66. PubMed ID: 1674685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.